Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats

Ton Ho Young, Hung Shang Tang, Herng Sheng Lee, Cheng Huei Hsiong, Oliver Yoa Pu Hu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Blood galactose clearance after an intravenous galactose load has been widely used as a quantitative liver function test. We have developed a novel quantitative rat liver function test, the galactose single point (GSP) method, to assess residual liver function with various injuries by measuring single time point galactose concentration in blood after an intravenous bolus injection of galactose. The goal of this study was to evaluate the influence of nonhepatic factors such as hyperglycemia on GSP and galactose elimination capacity (GEC) in rats. Four groups of animal studies were carried out, as follows: (1) normal control (NC), (2) streptozotocin-induced diabetes (DM), (3) carbon tetrachloride-induced hepatotoxicity (CCl4), and (4) streptozotocin-induced diabetes with CCl4-induced hepatotoxicity (DM + CCl4). The serum glucose levels in the diabetic groups (DM and DM + CCl4) were significantly increased compared with the NC and CCl4 groups (P < .001). A significant increase in hepatic activities of aspartate aminotransferase and alanine aminotransferase was observed in the CCl4-treated groups (CCl4 and DM + CCl4) compared with the NC and DM groups (P < .001). In comparison with the NC group, the values of GSP and GEC in the diabetic groups (DM and DM + CCl4) were significantly reduced (P < .001) and increased (P < .01), respectively. Galactose single point had highly significant correlations with GEC (P < .001). These results suggest that galactose metabolism tests-as quantitative parameters of liver function-should be interpreted with caution in the condition of a significant hyperglycemia.

Original languageEnglish
Pages (from-to)1265-1269
Number of pages5
JournalMetabolism: Clinical and Experimental
Volume56
Issue number9
DOIs
Publication statusPublished - Sep 1 2007
Externally publishedYes

Fingerprint

Galactose
Hyperglycemia
Liver
Experimental Diabetes Mellitus
Liver Function Tests
Control Groups
Carbon Tetrachloride
Aspartate Aminotransferases
Alanine Transaminase
Intravenous Injections
Glucose

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats. / Young, Ton Ho; Tang, Hung Shang; Lee, Herng Sheng; Hsiong, Cheng Huei; Hu, Oliver Yoa Pu.

In: Metabolism: Clinical and Experimental, Vol. 56, No. 9, 01.09.2007, p. 1265-1269.

Research output: Contribution to journalArticle

Young, Ton Ho ; Tang, Hung Shang ; Lee, Herng Sheng ; Hsiong, Cheng Huei ; Hu, Oliver Yoa Pu. / Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats. In: Metabolism: Clinical and Experimental. 2007 ; Vol. 56, No. 9. pp. 1265-1269.
@article{18825f5ab4fa4c10b4dbf54b0e28261e,
title = "Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats",
abstract = "Blood galactose clearance after an intravenous galactose load has been widely used as a quantitative liver function test. We have developed a novel quantitative rat liver function test, the galactose single point (GSP) method, to assess residual liver function with various injuries by measuring single time point galactose concentration in blood after an intravenous bolus injection of galactose. The goal of this study was to evaluate the influence of nonhepatic factors such as hyperglycemia on GSP and galactose elimination capacity (GEC) in rats. Four groups of animal studies were carried out, as follows: (1) normal control (NC), (2) streptozotocin-induced diabetes (DM), (3) carbon tetrachloride-induced hepatotoxicity (CCl4), and (4) streptozotocin-induced diabetes with CCl4-induced hepatotoxicity (DM + CCl4). The serum glucose levels in the diabetic groups (DM and DM + CCl4) were significantly increased compared with the NC and CCl4 groups (P < .001). A significant increase in hepatic activities of aspartate aminotransferase and alanine aminotransferase was observed in the CCl4-treated groups (CCl4 and DM + CCl4) compared with the NC and DM groups (P < .001). In comparison with the NC group, the values of GSP and GEC in the diabetic groups (DM and DM + CCl4) were significantly reduced (P < .001) and increased (P < .01), respectively. Galactose single point had highly significant correlations with GEC (P < .001). These results suggest that galactose metabolism tests-as quantitative parameters of liver function-should be interpreted with caution in the condition of a significant hyperglycemia.",
author = "Young, {Ton Ho} and Tang, {Hung Shang} and Lee, {Herng Sheng} and Hsiong, {Cheng Huei} and Hu, {Oliver Yoa Pu}",
year = "2007",
month = "9",
day = "1",
doi = "10.1016/j.metabol.2007.05.002",
language = "English",
volume = "56",
pages = "1265--1269",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Effects of hyperglycemia on quantitative liver functions by the galactose load test in diabetic rats

AU - Young, Ton Ho

AU - Tang, Hung Shang

AU - Lee, Herng Sheng

AU - Hsiong, Cheng Huei

AU - Hu, Oliver Yoa Pu

PY - 2007/9/1

Y1 - 2007/9/1

N2 - Blood galactose clearance after an intravenous galactose load has been widely used as a quantitative liver function test. We have developed a novel quantitative rat liver function test, the galactose single point (GSP) method, to assess residual liver function with various injuries by measuring single time point galactose concentration in blood after an intravenous bolus injection of galactose. The goal of this study was to evaluate the influence of nonhepatic factors such as hyperglycemia on GSP and galactose elimination capacity (GEC) in rats. Four groups of animal studies were carried out, as follows: (1) normal control (NC), (2) streptozotocin-induced diabetes (DM), (3) carbon tetrachloride-induced hepatotoxicity (CCl4), and (4) streptozotocin-induced diabetes with CCl4-induced hepatotoxicity (DM + CCl4). The serum glucose levels in the diabetic groups (DM and DM + CCl4) were significantly increased compared with the NC and CCl4 groups (P < .001). A significant increase in hepatic activities of aspartate aminotransferase and alanine aminotransferase was observed in the CCl4-treated groups (CCl4 and DM + CCl4) compared with the NC and DM groups (P < .001). In comparison with the NC group, the values of GSP and GEC in the diabetic groups (DM and DM + CCl4) were significantly reduced (P < .001) and increased (P < .01), respectively. Galactose single point had highly significant correlations with GEC (P < .001). These results suggest that galactose metabolism tests-as quantitative parameters of liver function-should be interpreted with caution in the condition of a significant hyperglycemia.

AB - Blood galactose clearance after an intravenous galactose load has been widely used as a quantitative liver function test. We have developed a novel quantitative rat liver function test, the galactose single point (GSP) method, to assess residual liver function with various injuries by measuring single time point galactose concentration in blood after an intravenous bolus injection of galactose. The goal of this study was to evaluate the influence of nonhepatic factors such as hyperglycemia on GSP and galactose elimination capacity (GEC) in rats. Four groups of animal studies were carried out, as follows: (1) normal control (NC), (2) streptozotocin-induced diabetes (DM), (3) carbon tetrachloride-induced hepatotoxicity (CCl4), and (4) streptozotocin-induced diabetes with CCl4-induced hepatotoxicity (DM + CCl4). The serum glucose levels in the diabetic groups (DM and DM + CCl4) were significantly increased compared with the NC and CCl4 groups (P < .001). A significant increase in hepatic activities of aspartate aminotransferase and alanine aminotransferase was observed in the CCl4-treated groups (CCl4 and DM + CCl4) compared with the NC and DM groups (P < .001). In comparison with the NC group, the values of GSP and GEC in the diabetic groups (DM and DM + CCl4) were significantly reduced (P < .001) and increased (P < .01), respectively. Galactose single point had highly significant correlations with GEC (P < .001). These results suggest that galactose metabolism tests-as quantitative parameters of liver function-should be interpreted with caution in the condition of a significant hyperglycemia.

UR - http://www.scopus.com/inward/record.url?scp=34547662258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547662258&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2007.05.002

DO - 10.1016/j.metabol.2007.05.002

M3 - Article

C2 - 17697871

AN - SCOPUS:34547662258

VL - 56

SP - 1265

EP - 1269

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 9

ER -